MAZABRAUD YANN (EVP, Head of International) sold 50.6% of their position (57K shares) of RHYTHM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $6.62M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+46.63K
Price / share
$6.80
Trade value
$317.05K
% of position
Common Stock
Shares
−2.30K
Price / share
$111.80
Trade value
$257.14K
% of position
Common Stock
Shares
−1K
Price / share
$112.86
Trade value
$112.86K
% of position
Common Stock
Shares
−3.60K
Price / share
$114.70
Trade value
$413.48K
% of position
Common Stock
Shares
−14.57K
Price / share
$115.43
Trade value
$1.68M
% of position
Common Stock
Shares
−18.21K
Price / share
$116.49
Trade value
$2.12M
% of position
Common Stock
Shares
−17.32K
Price / share
$117.47
Trade value
$2.03M
% of position
Net shares
−10.38K
Net value
-$6.30M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/12/2026 | M · Option Exercise | +46.63K | $6.80 | $317.05K | 70.6% | 66.03K | 112.66K |
| Common Stock Direct | 8/12/2026 | S · Sale | −2.30K | $111.80 | $257.14K | 2.0% | 112.66K | 110.36K |
| Common Stock Direct | 8/12/2026 | S · Sale | −1K | $112.86 | $112.86K | 0.9% | 110.36K | 109.36K |
| Common Stock Direct | 8/12/2026 | S · Sale | −3.60K | $114.70 | $413.48K | 3.3% | 109.36K | 105.75K |
| Common Stock Direct | 8/12/2026 | S · Sale | −14.57K | $115.43 | $1.68M | 13.8% | 105.75K | 91.18K |
| Common Stock Direct | 8/12/2026 | S · Sale | −18.21K | $116.49 | $2.12M | 20.0% | 91.18K | 72.97K |
| Common Stock Direct | 8/12/2026 | S · Sale | −17.32K | $117.47 | $2.03M | 23.7% | 72.97K | 55.66K |
| Total | −10.38K | -$6.30M | ||||||
Stock Options (Right to Buy)
Common Stock
46.63K shares
Shares
−46.63K
Strike price
6.80
Held after
35.88K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) Direct | Common Stock46.63K shares | 8/12/2026 | M · Option Exercise | −46.63K | 6.80 | — | 35.88K |